利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

42 条记录 (耗时 0.059 秒)

    COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
    1.
    发明申请
    COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR 有权
    化合物及其调节方法及其适应症

    公开(公告)号：US20090286782A1

    公开(公告)日：2009-11-19

    申请号：US12467194

    申请日：2009-05-15

    申请人： Prabha N. Ibrahim ,  Ryan Bremer ,  Jiazhong Zhang ,  Marika Nespi ,  Hanna Cho

    发明人： Prabha N. Ibrahim ,  Ryan Bremer ,  Jiazhong Zhang ,  Marika Nespi ,  Hanna Cho

    IPC分类号： A61K31/5377 ,  C07D487/04 ,  A61K31/519 ,  A61P19/02 ,  A61P35/00

    CPC分类号： C07D487/04 ,  A61K31/519

    摘要： Compounds and salts thereof, formulations thereof, conjugates thereof, derivatives thereof, forms thereof and uses thereof are described. In certain aspects and embodiments, the described compounds or salts thereof, formulations thereof, conjugates thereof, derivatives thereof, forms thereof are active on at least one of Fms protein kinase or Kit protein kinase. Also described are methods of use thereof to treat diseases and conditions, including diseases and conditions associated with activity of Fms protein kinases and/or Kit protein kinases, including rheumatoid arthritis, osteoarthritis, osteoporosis, peri-prosthetic osteolysis, systemic sclerosis, demyelinating disorders, multiple sclerosis, Charcot Marie Tooth syndrome, amyotrophic lateral sclerosis, Alzheimer's disease, Parkinson's disease, ulcerative colitis, Crohn's disease, immune thrombocytopenic purpura, myelopreparation for autologous transplantation, transplant rejection, nephritis, nephropathy, type I diabetes, acute pain, inflammatory pain, neuropathic pain, breast cancer, prostate cancer, pancreatic cancer, lung cancer, ovarian cancer, gliomas, glioblastomas, neurofibromatosis, osteolytic bone metastases, and giant cell tumors.

    摘要翻译： 其化合物及其盐，其制剂，其缀合物，其衍生物，其形式及用途。 在某些方面和实施方案中，所述的化合物或其盐，其制剂，其缀合物，其衍生物，其形式在Fms蛋白激酶或Kit蛋白激酶中的至少一种上是有活性的。 还描述了其用于治疗疾病和病症的方法，包括与Fms蛋白激酶和/或Kit蛋白激酶（包括类风湿性关节炎，骨关节炎，骨质疏松症，骨质疏松症，系统性硬化症，脱髓鞘疾病， 多发性硬化症，Charcot玛丽牙综合征，肌萎缩性侧索硬化，阿尔茨海默病，帕金森病，溃疡性结肠炎，克罗恩病，免疫性血小板减少性紫癜，自体移植用骨髓制剂，移植排斥，肾炎，肾病，I型糖尿病，急性疼痛， 神经性疼痛，乳腺癌，前列腺癌，胰腺癌，肺癌，卵巢癌，神经胶质瘤，成胶质细胞瘤，神经纤维瘤病，溶骨性骨转移和巨细胞肿瘤。

    Compounds and methods for kinase modulation, and indications therefor
    2.
    发明授权
    Compounds and methods for kinase modulation, and indications therefor 有权
    用于激酶调节的化合物和方法及其适应症

    公开(公告)号：US08912204B2

    公开(公告)日：2014-12-16

    申请号：US13411919

    申请日：2012-03-05

    申请人： Prabha N. Ibrahim ,  Ryan Bremer ,  Jiazhong Zhang ,  Marika Nespi ,  Hanna Cho

    发明人： Prabha N. Ibrahim ,  Ryan Bremer ,  Jiazhong Zhang ,  Marika Nespi ,  Hanna Cho

    IPC分类号： A01N43/90 ,  A61K31/519 ,  C07D487/00 ,  C07D487/04

    CPC分类号： C07D487/04 ,  A61K31/519

    摘要： Compounds of Formula I: and salts thereof, formulations thereof, conjugates thereof, derivatives thereof, forms thereof and uses thereof are described. In certain aspects and embodiments, the described compounds or salts thereof, formulations thereof, conjugates thereof, derivatives thereof, forms thereof are active on at least one of Fms protein kinase or Kit protein kinase. Also described are methods of use thereof to treat diseases and conditions, including diseases and conditions associated with activity of Fms protein kinases and/or Kit protein kinases, including rheumatoid arthritis, osteoarthritis, osteoporosis, peri-prosthetic osteolysis, systemic sclerosis, demyelinating disorders, multiple sclerosis, Charcot Marie Tooth syndrome, amyotrophic lateral sclerosis, Alzheimer's disease, Parkinson's disease, ulcerative colitis, Crohn's disease, immune thrombocytopenic purpura, myelopreparation for autologous transplantation, transplant rejection, nephritis, nephropathy, type I diabetes, acute pain, inflammatory pain, neuropathic pain, breast cancer, prostate cancer, pancreatic cancer, lung cancer, ovarian cancer, gliomas, glioblastomas, neurofibromatosis, osteolytic bone metastases, and giant cell tumors.

    摘要翻译： 描述了式I化合物及其盐，其制剂，其结合物，其衍生物，其形式及其用途。 在某些方面和实施方案中，所述的化合物或其盐，其制剂，其缀合物，其衍生物，其形式在Fms蛋白激酶或Kit蛋白激酶中的至少一种上是有活性的。 还描述了其用于治疗疾病和病症的方法，包括与Fms蛋白激酶和/或Kit蛋白激酶（包括类风湿性关节炎，骨关节炎，骨质疏松症，骨质疏松症，系统性硬化症，脱髓鞘疾病， 多发性硬化症，Charcot玛丽牙综合征，肌萎缩性侧索硬化，阿尔茨海默病，帕金森病，溃疡性结肠炎，克罗恩病，免疫性血小板减少性紫癜，自体移植用骨髓制剂，移植排斥，肾炎，肾病，I型糖尿病，急性疼痛， 神经性疼痛，乳腺癌，前列腺癌，胰腺癌，肺癌，卵巢癌，神经胶质瘤，成胶质细胞瘤，神经纤维瘤病，溶骨性骨转移和巨细胞肿瘤。

    Compounds and methods for kinase modulation, and indications therefor
    6.
    发明授权
    Compounds and methods for kinase modulation, and indications therefor 有权
    用于激酶调节的化合物和方法及其适应症

    公开(公告)号：US08158636B2

    公开(公告)日：2012-04-17

    申请号：US12467194

    申请日：2009-05-15

    申请人： Prabha N. Ibrahim ,  Ryan Bremer ,  Jiazhong Zhang ,  Marika Nespi ,  Hanna Cho

    发明人： Prabha N. Ibrahim ,  Ryan Bremer ,  Jiazhong Zhang ,  Marika Nespi ,  Hanna Cho

    IPC分类号： A01N43/90 ,  A61K31/519 ,  C07D487/00

    CPC分类号： C07D487/04 ,  A61K31/519

    摘要： Compounds and salts thereof, formulations thereof, conjugates thereof, derivatives thereof, forms thereof and uses thereof are described. In certain aspects and embodiments, the described compounds or salts thereof, formulations thereof, conjugates thereof, derivatives thereof, forms thereof are active on at least one of Fms protein kinase or Kit protein kinase. Also described are methods of use thereof to treat diseases and conditions, including diseases and conditions associated with activity of Fms protein kinases and/or Kit protein kinases, including rheumatoid arthritis, osteoarthritis, osteoporosis, peri-prosthetic osteolysis, systemic sclerosis, demyelinating disorders, multiple sclerosis, Charcot Marie Tooth syndrome, amyotrophic lateral sclerosis, Alzheimer's disease, Parkinson's disease, ulcerative colitis, Crohn's disease, immune thrombocytopenic purpura, myelopreparation for autologous transplantation, transplant rejection, nephritis, nephropathy, type I diabetes, acute pain, inflammatory pain, neuropathic pain, breast cancer, prostate cancer, pancreatic cancer, lung cancer, ovarian cancer, gliomas, glioblastomas, neurofibromatosis, osteolytic bone metastases, and giant cell tumors.

    摘要翻译： 其化合物及其盐，其制剂，其缀合物，其衍生物，其形式及用途。 在某些方面和实施方案中，所述的化合物或其盐，其制剂，其缀合物，其衍生物，其形式在Fms蛋白激酶或Kit蛋白激酶中的至少一种上是有活性的。 还描述了其用于治疗疾病和病症的方法，包括与Fms蛋白激酶和/或Kit蛋白激酶（包括类风湿性关节炎，骨关节炎，骨质疏松症，骨质疏松症，系统性硬化症，脱髓鞘疾病， 多发性硬化症，Charcot Marie Tooth综合征，肌萎缩性侧索硬化，阿尔茨海默病，帕金森病，溃疡性结肠炎，克罗恩病，免疫性血小板减少性紫癜，自体移植用骨髓制剂，移植排斥，肾炎，肾病，I型糖尿病，急性疼痛， 神经性疼痛，乳腺癌，前列腺癌，胰腺癌，肺癌，卵巢癌，神经胶质瘤，成胶质细胞瘤，神经纤维瘤病，溶骨性骨转移和巨细胞肿瘤。

    COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
    7.
    发明申请
    COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR 有权

    公开(公告)号：US20150166547A1

    公开(公告)日：2015-06-18

    申请号：US14571186

    申请日：2014-12-15

    申请人： Prabha N. Ibrahim ,  Ryan Bremer ,  Jiazhong Zhang ,  Marika Nespi ,  Hanna Cho

    发明人： Prabha N. Ibrahim ,  Ryan Bremer ,  Jiazhong Zhang ,  Marika Nespi ,  Hanna Cho

    IPC分类号： C07D487/04

    CPC分类号： C07D487/04 ,  A61K31/519

    摘要： Compounds and salts thereof, formulations thereof, conjugates thereof, derivatives thereof, forms thereof and uses thereof are described. In certain aspects and embodiments, the described compounds or salts thereof, formulations thereof, conjugates thereof, derivatives thereof, forms thereof are active on at least one of Fms protein kinase or Kit protein kinase. Also described are methods of use thereof to treat diseases and conditions, including diseases and conditions associated with activity of Fms protein kinases and/or Kit protein kinases, including rheumatoid arthritis, osteoarthritis, osteoporosis, peri-prosthetic osteolysis, systemic sclerosis, demyelinating disorders, multiple sclerosis, Charcot Marie Tooth syndrome, amyotrophic lateral sclerosis, Alzheimer's disease, Parkinson's disease, ulcerative colitis, Crohn's disease, immune thrombocytopenic purpura, myelopreparation for autologous transplantation, transplant rejection, nephritis, nephropathy, type I diabetes, acute pain, inflammatory pain, neuropathic pain, breast cancer, prostate cancer, pancreatic cancer, lung cancer, ovarian cancer, gliomas, glioblastomas, neurofibromatosis, osteolytic bone metastases, and giant cell tumors.